|
Report Date : |
26.05.2014 |
IDENTIFICATION DETAILS
|
Name : |
FRONTIER LIFE SCIENCES INC |
|
|
|
|
Registered Office : |
1670-142 Naracho Aobaku Yokohama 227-0036 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
30.06.2013 |
|
|
|
|
Date of Incorporation : |
February 2009 |
|
|
|
|
Com. Reg. No.: |
0200-01-060673 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Importer, Exporter and wholesaler of health food & materials, functional foods |
|
|
|
|
No of Employees : |
1 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
COMPANY NAME:
FRONTIER
LIFE SCIENCES INC
REGD NAME:
Frontier Life Science KK
MAIN OFFICE:
1670-142 Naracho Aobaku Yokohama 227-0036
JAPAN
Tel: 045-516-9405
Fax: 045-516-2210
URL: Error! Hyperlink reference not valid.frontierlifescience.com
E-Mail address: (thru the URL)
ACTIVITIES:
Import, export, wholesale of health food
& materials, functional foods
BRANCHES:
Tokyo
OVERSEAS:
China (partner)
FACTORIES:
(subcontracted)
OFFICERS:
KAZUAKI IHARA, PRES
Yen Amount: In
million Yen, unless otherwise stated
SUMMARY:
FINANCES R/WEAK A/SALES Yen
111 M
PAYMENTS SLOW
BUT CORRECT CAPITAL Yen 8 M
TREND UP WORTH Yen 16 M
STARTED 2009 EMPLOYES 1
COMMENT:
TRADING FIRM
SPECIALIZING IN HEALTH FOODS & MATERIALS.
FINANCIAL SITUATION CONSIDERED RATHER WEAK BUT SHOULD BE GOOD FOR
MODERATE BUSINESS ENGAGEMENTS.
HIGHLIGHTS:
The subject
company was established by Kazuaki Ihara in order to make most of his
experience in the subject line of business.
His is a one-man trading firm for import, export and wholesale of health
foods & materials, functional foods, other.
Materials are imported from China, other. Clients include pharmaceutical mfrs, wholesalers,
other.
FINANCIAL
INFORMATION:
The sales volume
for Jun/2012 fiscal term amounted to Yen 111 million, a 59% up from Yen 70
million in the previous term. Newly
handled inguard and turmeric were in good demand and sales rose. The recurring profit was posted at Yen 12
million and the net profit at Yen 8 million, respectively, compared with Yen 4
million recurring profit and Yen 3 million net profit, respectively, a year
ago.
For the term that
ended Jun 2013 the recurring profit was projected at Yen 15 million and the net
profit at Yen 10 million, respectively, on a 4% rise in turnover, to Yen 115
million. Final results are yet to be
released. No data are available from
outside sources.
The financial
situation is considered RATHER WEAK but should be good for MODERATE business
engagements.
REGISTRATION:
Date
Registered: Feb 2009
Regd
No.: 0200-01-060673
(Yokohama-Aobaku)
Legal
Status: Limited
Company (Kabushiki Kaisha)
Authorized: 640
shares
Issued: 160
shares
Sum:
Yen
8 million
Major shareholders
(%): Kazuaki Ihara (100)
Nothing detrimental is known as to his
commercial morality.
OPERATION:
Activities: Imports, exports
and wholesales: health foods & health food materials (medical plant,
inguard, turmeric, krill oil, other) (--50%), functional foods (subcontracted
mfg) (40%), nursing-care goods & supplies, other (10%)
Clients: [Mfrs,
wholesalers] Nippon Tablet (25%), HABA Laboratories Inc, API Co, Sansho
Pharmaceutical, Nikken Medical Corp, Shunyodo Yakubo, other
No.
of accounts: 300
Domestic
areas of activities: Nationwide
Suppliers: [Mfrs,
wholesalers] Mitsubishi Gas Chemical, Bio Active Japan, Nippon Tablet,
Phytopharme Co, other
Payment
record: Slow But Correct
Location: Business area in Yokohama. Office premises at the caption address are
owned by Kazuaki Ihara as his private residence and maintained satisfactorily.
Bank
References:
Bank
of Yokohama (Tama-Plaza)
MUFG
(Aobadai)
Relations:
Money deposits & transfers only
FINANCES (In Million
Yen)
|
Terms Ending: |
30/06/2013 |
30/06/2012 |
30/06/2011 |
30/06/2010 |
|
|
Annual
Sales |
|
115 |
111 |
70 |
34 |
|
Recur.
Profit |
|
15 |
12 |
4 |
|
|
Net
Profit |
|
10 |
8 |
3 |
-3 |
|
Total
Assets |
|
|
31 |
15 |
7 |
|
Current
Assets |
|
|
29 |
15 |
|
|
Current
Liabs |
|
|
14 |
6 |
|
|
Net
Worth |
|
|
16 |
8 |
5 |
|
Capital,
Paid-Up |
|
|
8 |
8 |
8 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
3.60 |
58.57 |
105.88 |
13.33 |
|
|
Current Ratio |
|
.. |
207.14 |
250.00 |
.. |
|
N.Worth Ratio |
.. |
51.61 |
53.33 |
71.43 |
|
|
R.Profit/Sales |
|
13.04 |
10.81 |
5.71 |
.. |
|
N.Profit/Sales |
8.70 |
7.21 |
4.29 |
-8.82 |
|
|
Return On Equity |
.. |
50.00 |
37.50 |
.. |
|
Notes: Forecast (or estimated) figures for the 30/06/2013 fiscal term.
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
DPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to
overcome financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.